The American Academy of Ophthalmology (AAO), backed by the Royal Australian and New Zealand College of Ophthalmologists, has called on ophthalmic imaging device manufacturers to standardise image formats in accordance with the Digital Imaging and Communications in Medicine (DICOM) standard.
Australia’s first clinical trials into a new gene therapy to treat dry age-related macular degeneration (AMD) have begun at the Centre for Eye Research Australia (CERA). Two studies, Horizon and
For those who checked in online, RANZCO NZ 2021 virtual exhibitor Optos was displaying its most powerful retinal imaging technology to date, the Silverstone. The only ultra-widefield retinal imaging device with integrated, UWF-guided swept-source OCT,
US clinics have reported encountering patients who developed photokeratitis after exposure to ultraviolet (UV) germicidal lamps while attempting to eliminate coronavirus from homes and
A Moorfields Eye Hospital and University College of London (UCL) study has linked low to moderate alcohol consumption with a reduced risk of cataract surgery. The collaborative study found wine
There is greater uncertainty surrounding New Zealand female employees’ likeliness and willingness to get vaccinated against Covid-19 compared with the male counterparts, a new report found. The New
Glaukos has been named as the exclusive distributor of Japanese ophthalmic healthcare company Santen’s Preserflo Microshunt in Australia and New Zealand.
Multi-award-winning actor, comedian, author and television personality Whoopi Goldberg suffers from acute angle closure (AAC) glaucoma and is an outspoken proponent for medical cannabis, which she uses as part of her treatment.
A review of emerging contact lens (CL) technologies by the University of Waterloo, Canada, has highlighted several innovative concepts spanning treatment, diagnostics, monitoring and drug delivery systems.
Designed to fuel an optometry or ophthalmology practice’s dry eye offering, French-based ESW Vision’s Tearcheck and Tearstim compact diagnostic and treatment options were on show for the first time in New Zealand on Ophthalmic Instrument Company’s (OIC’s) stand.
New to New Zealand and Australia, Zeiss product specialists Lahiru Gunasena and Hollie McDonald were proudly displaying Zeiss’ next-generation OCT, the Cirrus 6000, which can scan a patient’s eye in 0.4 seconds.
Taking advantage of the opportunity to actually talk to ophthalmologists face-to-face, Device Technologies’ Diego Sonderegger said he was delighted to finally discuss Swiss-based Oertli’s extremely lightweight surgical platform, the Catarhex 3, at the 2021 RANZCO NZ meeting.